Jazz Pharmaceuticals
JAZZ
JAZZ
427 hedge funds and large institutions have $7.37B invested in Jazz Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 74 funds opening new positions, 185 increasing their positions, 116 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 417 → 427 (+10)
2.4% more ownership
Funds ownership: 88.02% → 90.42% (+2.4%)
29% less call options, than puts
Call options by funds: $26.5M | Put options by funds: $37.5M
Holders
427
Holding in Top 10
6
Calls
$26.5M
Puts
$37.5M
Top Buyers
| 1 | +$120M | |
| 2 | +$61.6M | |
| 3 | +$46.6M | |
| 4 |
JP Morgan Chase
New York
|
+$46.3M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$46M |
Top Sellers
| 1 | -$257M | |
| 2 | -$168M | |
| 3 | -$142M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$73.5M |
| 5 |
SIG
Senator Investment Group
New York
|
-$50.6M |